Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0000950170-25-002115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-06 | 2025-01-02+ | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $12.17 | -7,978 | 64.0K | -11% | -$97.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | S | D | 556 | $12.03 | 71,470 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-03 | S | D | 7,422 | $12.18 | 64,048 | D | — | — |